Cergutuzumab amunaleukin

(Synonyms: CEA-IL2v; RG 7813; RO 6895882)
Customer Review

Based on 1 Customer Validation

Cergutuzumab amunaleukin (CEA-IL2v) is a monomeric carcinoembryonic antigen (CEA)-targeted IL-2 variant-based immunocytokine. Cergutuzumab amunaleukin has immunostimulating and antineoplastic activities.

For research use only. We do not sell to patients.

  • Purity: 99.5%
  • CAS No.: 1509916-03-3
  • Molecular Weight:162.05 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00